It should constitute assessing serial disease symptoms such as peripheral neuropathy, volume status, eyes, skin, and organomegaly as well as of lab values such as M-protein, VEGF, and affected endocrine parameters. This evidence concerns the gene MYOM2 and peripheral neuropathy.